Beta blockers could benefit patients with HFPEF
11/20/2014
A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today...
Cooling techniques developed, with the help of songbirds, to safely map the human brain
11/20/2014
A new diagnostic technique -- resulting from monitoring thousands of courtship calls from songbirds -- can be used to safely map the human brain during complex neurosurgery, according to research...
The body's own cancer defence knocked out by Chlamydia
11/20/2014
By breaking down the cancer-suppressing protein p53, Chlamydia prevent programmed cell death and thereby favour the process of cancer developmentAn infection with chlamydia trachomatis favours...
Cryopreservation could extend the shelf life of blood from weeks to years
11/20/2014
Engineers at Oregon State University have identified a method to rapidly prepare frozen red blood cells for transfusions, which may offer an important new way to manage the world's blood supply.
In mouse model severe inflammations triggered by potential treatment approach for lymphomas
11/20/2014
The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma).
Anti-leukemia drug may also work against ovarian cancer
11/20/2014
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer - and likely other cancers as well, report researchers at...
Genetic replication study could lead to new cancer treatments
11/20/2014
A group of scientists have made a breakthrough in the study of how genetic material is replicated. Their findings could have implications for cancer research.
Risk for cancer in the eye may be increased by TNF inhibitors
11/20/2014
One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors.
How thiazolidinediones work to improve glucose metabolism
11/20/2014
A research team led by Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) has uncovered surprising new findings that underscore the role of an important signaling pathway...
TopBP1 a sweet spot for treatment in multiple cancers
11/20/2014
A compound called calcein may act to inhibit topoisomerase IIβ-binding protein 1 (TopBP1), which enhances the growth of tumors, said researchers from Baylor College of Medicine in a report that...